Emyria has expanded clinical service subsidiary Emerald Clinics with the addition of a second site in Melbourne. The move comes after a record number of patient appointments in January.

Emyria managing director Dr Michael Winlo said the new site is co-located with Victorian Counselling and Psychological Services and offers unique collaboration opportunities with mental health clinicians including psychologists and psychiatrists.

He added: “We anticipate these collaborations will assist our pivotal drug registration clinical trials for EMD-003 – a cannabinoid medicine targeting unmet needs in mental health – as well as support the development of evidence-based clinical protocols and therapy standards for psychedelic-assisted therapy trials.

“Such trials are currently in development with partner Mind Medicine Australia to help improve our understanding of the role these treatments might play in treating serious mental health concerns like PTSD and major depression.”

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...